After Hours
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours.
Stocks Info
The company is listed on the NASDAQ and operates within the Biotechnology industry segment. The current market capitalization of Puma Biotechnology Inc is $140.40M. A total of 0.2 million shares were traded on the day, compared to an average of 550.38K shares.
In the most recent transaction, NOUGUES MAXIMO F sold 10,227 shares of PBYI for 3.15 per share on Jan 02 ’25. After the transaction, the Chief Financial Officer now owns 152,295 company shares. In a previous transaction on Jan 02 ’25, Ludwig Jeffrey Jerome sold 9,437 shares at 3.15 per share. PBYI shares that Chief Commercial Officer owns now total 108,951.
Among the insiders who sold shares, HUNT DOUGLAS M disposed of 8,633 shares on Jan 02 ’25 at a per-share price of $3.15. This resulted in the insider holding 124,594 shares of PBYI after the transaction. In another insider transaction, AUERBACH ALAN H sold 33,841 shares at $3.15 per share on Jan 02 ’25. Company shares held by the President and CEO now total 7,029,674.
It has been observed that price targets are rarely accurate, but they can exert some influence from time to time, and are often accepted as valuable in the market. In terms of 52-week highs and lows, PBYI has a high of $7.73 and a low of $2.22.
As of this writing, PBYI has an earnings estimate of $0.14 per share for the current quarter. EPS was calculated based on a consensus of 2.0 estimates, with a high estimate of $0.15 per share and a lower estimate of $0.13.
Balance Sheet Annually/Quarterly
An equity investor’s investment can be viewed on a balance sheet by looking at what assets and liabilities the company has. Investors can determine the company’s prospects by calculating its financial ratios based on this information. PBYI’s latest balance sheet shows that the firm has $82.11M in Cash & Short Term Investments as of fiscal 2021. There were $116.64M in debt and $109.59M in liabilities at the time. Its Book Value Per Share was $1.45, while its Total Shareholder’s Equity was -$2.45M.
Analysts Opinion
There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for PBYI is Buy with a score of 3.00.
